1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue

IMARC’s latest study “Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue” provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic Oncology drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report

Key Questions Answered in this Report?

What are the historical, current and future trends in the generic market?
What are the historical, current and future trends in the generic oncology market?
What is the competitive structure of the generic market and who are the key players?
What is the competitive structure of the generic oncology market and who are the key players?
What are the key success factors for generic oncology drug manufacturers?
How are generic oncology drugs manufactured?
What are the raw material requirements and their cost for manufacturing generic oncology drugs?
What are the land and construction requirements and their cost for manufacturing generic oncology drugs?
What are the machinery requirements and their cost for manufacturing generic oncology drugs?
What are the packaging requirements and their cost for manufacturing generic oncology drugs?
What are the utility requirements and their cost for manufacturing generic oncology drugs?
What are the manpower requirements and their cost for manufacturing generic oncology drugs?
What is the total capital investment required for setting up a generic oncology drug manufacturing plant
What are the operational costs for setting up a generic oncology drug manufacturing plant?
How much income will the generic oncology drug manufacturing plant generate?
What will be the profitability of the generic oncology drug manufacturing plant?
What will be the NPV of the generic oncology drug manufacturing plant?
What will be the payback period of the generic oncology drug manufacturing plant?

Table Of Contents

Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue
1 Research Methodology
2 Report Summary
3 Introduction
4 Global Generic Drug Market
4.1 Classification of Generic Drugs
4.2 Market Trends
4.2.1 Current and Historical Market Trends
4.2.2 Market Breakup by Region
4.2.3 Major Players in the Generic Drug Industry
4.2.4 Market Forecast
4.3 Value Chain Analysis of Generic Drugs
4.4 Key Success Factors Driving the Generic Drug Industry
4.6 Regulations in the Generic Drug Industry
5 Global Cancer Generics Market
5.1 Global Cancer Statistics
5.2 Current and Historical Market Trends
5.3 Top Cancer Drugs
5.4 Top Players in the Cancer Generics Market
5.5 Market Forecast
6 Manufacturing Process
6.1 Detailed Process Flow (Tablet)
6.2 Detailed Process Flow (Injectables)
6.3 Cancer Generic Manufacturing Plant: Raw Material Requirements
6.3.1 Cancer Generic Drug (Tablet)
6.3.2 Cancer Generic Drug (Injectables)
7 Project Details, Requirements and Costs Involved
7.1 Land, Location and Site Development
7.2 Plant Machinery
7.3 Machinery Pictures
7.4 Raw Materials
7.5 Packaging
7.6 Utilities
7.7 Manpower
7.8 Other Capital Investments
8 Cancer Generic Drug Manufacturing Plant: Project Economics
8.1 Capital Cost of the Project
8.2 Loans and Financial Assistance
8.3 Techno-Economic Parameters
8.4 Product Pricing
8.5 Income Projections
8.6 Expenditure Projections
8.7 Financial Analysis

List of Figures

Figure 1 1: Global: Cancer Incidence: Breakup by Country (in %), 2015
Figure 4 1: Global: Generics Market: Sales Value (in US$ Billion), 2011-2015
Figure 4 2: Global: Generics Market: Breakup by Country (in %), 2015
Figure 4 3: Global: Generics Market: Sales Value (in US$ Billion), 2016-2021
Figure 4 4: Global: Generics Market: Value Chain
Figure 5 1: Global: Cancer Incidence: 2008-2015
Figure 5 2: Global: Cancer Incidence: Breakup by Country (in %), 2015
Figure 5 3: Global: Cancer Generics Market: Sales Value (in US$ Billion), 2008-2015
Figure 5 4: Global: Cancer Generics Market Forecast: Sales Value (in US$ Billion), 2015-2020
Figure 6 1: Cancer Generic (Tablet) Manufacturing: Detailed Process Flow
Figure 6 2: Cancer Generic (Injectable) Manufacturing: Detailed Process Flow
Figure 6 3: Cancer Generic (Imatinib Tablet) Manufacturing Process: Conversion Rate of Feedstocks
Figure 6 4: Cancer Generic (Paclitaxel) Manufacturing Process: Conversion Rate of Feedstocks
Figure 7 1: Cancer Generic Manufacturing Plant: Primary Packaging
Figure 7 2: Cancer Generic Manufacturing Plant: Secondary Packaging
Figure 7 3: Cancer Generic Manufacturing Plant: Tertiary Packaging
Figure 8 1: Cancer Generic Manufacturing Plant: Breakup of Capital Costs (in %)
Figure 8 2: Cancer Generic Manufacturing Plant: Breakup of Production Costs (in %)

List of Tables

Table 4 1: Global: Generics Market: Revenues of Key Players (in US$ Billion), 2015
Table 7 1: Cancer Generic Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 7 2: Cancer Generic Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 7 3: Cancer Generic Manufacturing Plant: Machinery Costs (in US$)
Table 7 4: Cancer Generic Manufacturing Plant: Raw Material Requirements (in Kg/Day)
Table 7 5: Cancer Generic Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 7 6: Cancer Generic Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 8 1: Cancer Generic Manufacturing Plant: Capital Costs (in US$)
Table 8 2: Details of Financial Assistance Offered by Financial Institutions
Table 8 3: Cancer Generic Manufacturing Plant: Loan Installments
Table 8 4: Cancer Generic Manufacturing Plant: Techno- Economic Parameters
Table 8 5: Cancer Generic Manufacturing Plant: Income Projections (in US$)
Table 8 6: Cancer Generic Manufacturing Plant: Expenditure Projections (in US$)
Table 8 7: Cancer Generic Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
Table 8 8: Cancer Generic Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 Global Cancer Diagnostics Market: New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

2017 Global Cancer Diagnostics Market: New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. VPGMarketResearch.com's new report is a study of the major business opportunities emerging in the global cance ...

2017 World Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

2017 World Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. VPGMarketResearch.com's new report is a seven-country strategic analysis of the major business opportunities ...


Download Unlimited Documents from Trusted Public Sources

Hormone and Therapy Market in Pakistan and the US

  • March 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Hepatitis Statistics and Therapy Market in the UK

  • March 2017
    10 pages
  • Hepatitis  

    Therapy  

    Antiviral  

  • United Kingdom  

View report >

Opioid Market in the US

  • March 2017
    13 pages
  • Opioid  

  • United States  

View report >

Related Market Segments :

Cancer
Oncology

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.